CTMX
CytomX Therapeutics Inc

4,458
Mkt Cap
$938.67M
Volume
3.03M
52W High
$6.15
52W Low
$0.40
PE Ratio
13.25
CTMX Fundamentals
Price
$5.54
Prev Close
$5.72
Open
$5.69
50D MA
$4.22
Beta
1.37
Avg. Volume
2.74M
EPS (Annual)
$0.3761
P/B
8.52
Rev/Employee
$1.14M
Loading...
Loading...
News
all
press releases
CytomX Therapeutics (NASDAQ:CTMX) Sets New 1-Year High - Should You Buy?
CytomX Therapeutics (NASDAQ:CTMX) Sets New 1-Year High - Here's Why...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
CytomX Therapeutics (NASDAQ:CTMX) Shares Down 5.3% - Here's Why
CytomX Therapeutics (NASDAQ:CTMX) Trading Down 5.3% - Should You Sell...
MarketBeat·4d ago
News Placeholder
Guggenheim Upgrades CytomX Therapeutics (NASDAQ:CTMX) to "Strong-Buy"
Guggenheim upgraded shares of CytomX Therapeutics to a "strong-buy" rating in a research note on Tuesday...
MarketBeat·4d ago
News Placeholder
Qiagen (QGEN) Soars 16.6%: Is Further Upside Left in the Stock?
Qiagen (QGEN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks·4d ago
News Placeholder
CytomX Therapeutics, Inc. (NASDAQ:CTMX) Receives Average Recommendation of "Moderate Buy" from Brokerages
CytomX Therapeutics, Inc. (NASDAQ:CTMX - Get Free Report) has been given an average rating of "Moderate Buy" by the seven brokerages that are presently covering the stock, Marketbeat.com reports. One...
MarketBeat·5d ago
News Placeholder
Formidable Asset Management LLC Sells 194,513 Shares of CytomX Therapeutics, Inc. $CTMX
Formidable Asset Management LLC reduced its position in shares of CytomX Therapeutics, Inc. (NASDAQ:CTMX - Free Report) by 62.2% in the third quarter, according to its most recent filing with the...
MarketBeat·5d ago
News Placeholder
CytomX Stock Rises 31% in a Month: Here's What You Should Know
CTMX's share jumps 31% in a month after it outlined pipeline progress and 2026 goals led by Varseta-M in advanced colorectal cancer.
Zacks·6d ago
News Placeholder
CytomX Therapeutics (NASDAQ:CTMX) Reaches New 12-Month High - Here's What Happened
CytomX Therapeutics (NASDAQ:CTMX) Hits New 12-Month High - Should You Buy...
MarketBeat·9d ago
News Placeholder
CytomX Therapeutics (NASDAQ:CTMX) Hits New 1-Year High - Here's Why
CytomX Therapeutics (NASDAQ:CTMX) Hits New 52-Week High - Should You Buy...
MarketBeat·23d ago
News Placeholder
237,081 Shares in CytomX Therapeutics, Inc. $CTMX Acquired by Precision Wealth Strategies LLC
Precision Wealth Strategies LLC bought a new position in shares of CytomX Therapeutics, Inc. (NASDAQ:CTMX - Free Report) during the third quarter, according to the company in its most recent 13F...
MarketBeat·1mo ago
<
1
2
...
>

Latest CTMX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.